Total investments

153

Average round size

32M

Portfolio companies

5

Rounds per year

9.56

Lead investments

42

Follow on index

0.38

Stages of investment
SeedPrivate EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyHealth CareTherapeuticsBiopharma

Summary

Novo Seeds is the famous VC, which was founded in 2007. The leading representative office of defined VC is situated in the Hellerup. The fund was located in Europe if to be more exact in Denmark.

Among the most popular portfolio startups of the fund, we may highlight Galecto Biotech. Among the most successful fund investment fields, there are Biopharma, Chemical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Denmark. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Novo Seeds, startups are often financed by M Ventures, SEED Capital, Sofinnova Investments. The meaningful sponsors for the fund in investment in the same round are M Ventures, Sofinnova Investments, Lundbeckfonden Emerge. In the next rounds fund is usually obtained by M Ventures, Sunstone Life Science Ventures, Lundbeckfonden Emerge.

Besides them, we counted 5 critical employees of this fund in our database.

The real fund results show that this VC is 18 percentage points more often commits exit comparing to other companies. The higher amount of exits for fund were in 2014. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 deals per year. The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. Comparing to the other companies, this Novo Seeds performs on 22 percentage points less the average number of lead investments.

Show more

Investments analytics

Analytics

Total investments
153
Lead investments
42
Rounds per year
9.56
Follow on index
0.38
Investments by industry
  • Biotechnology (5)
  • Health Care (4)
  • Therapeutics (2)
  • Biopharma (1)
Investments by region
  • Netherlands (1)
  • Belgium (1)
  • Denmark (2)
  • United States (1)
Peak activity year
2018

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
5
Group Appearance index
0.02
Avg. company exit year
13

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Chromologics 01 Jun 2021 Biotechnology Seed 4M Denmark, Capital Region of Denmark, Denmark
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.